6-Hydroxypurine
CAS No. 68-94-0
6-Hydroxypurine( 6-Hydroxypurine | NSC 14665 | NSC 129419 )
Catalog No. M15636 CAS No. 68-94-0
A purine and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 43 | In Stock |
|
| 25MG | 29 | In Stock |
|
| 50MG | 34 | In Stock |
|
| 100MG | 47 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 105 | In Stock |
|
| 1G | 152 | In Stock |
|
Biological Information
-
Product Name6-Hydroxypurine
-
NoteResearch use only, not for human use.
-
Brief DescriptionA purine and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway.
-
DescriptionA purine and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway.
-
In Vitro——
-
In Vivo——
-
Synonyms6-Hydroxypurine | NSC 14665 | NSC 129419
-
PathwayOthers
-
TargetOther Targets
-
RecptorPurine nucleoside phosphorylase
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number68-94-0
-
Formula Weight136.11
-
Molecular FormulaC5H4N4O
-
Purity>98% (HPLC)
-
SolubilityDMSO: 0.4 mg/mL (2.93 mM)
-
SMILESO=C1NC=NC2=C1N=CN2
-
Chemical Name1,9-dihydro-6H-purin-6-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Cavidine
Cavidine ((+)-Cavidine) is a selective COX-2 inhibitor which possesses anti-inflammatory activity. Cavidine can be used for the research of skin injuries, hepatitis, cholecystitis, and scabies. Cavidine ameliorates LPS -induced acute lung injury via NF-κB signaling pathway.
-
AHR antagonist 5 fre...
AHR antagonist 5 free base is an orally active AHR antagonist with IC50 of approximately 35-150 nM in human and rodent cell lines, and exhibits anticancer activity.
-
γ-2-MSH (41-58), ami...
Melanocortin (MC) 3-MSH (Melanocyte-Stimulating Hormone) is believed to signal through the MC 3 receptor. It induces a sustained increase in intracellular free calcium levels ([Ca2+]i) in a subpopulation of pituitary cells. Most of the cells responding to 3-MSH express more than one pituitary hormone mRNA. The effect of 3-MSH is blocked by SHU9119, a MC3R and MC4R antagonist, in only 50% of the responsive cells, suggesting that in half of these cells the mediating receptor is not the MC3R. Low picomolar doses of 3-MSH increase [Ca2+]i in the growth hormone (GH)- and prolactin (PRL)-secreting GH3 cell line.
Cart
sales@molnova.com